| Prescribing and monitoring clozapine in Christchurch. | |
| | |
MedLine Citation:
|
PMID: 18668375 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: The aim of the study was to identify the pattern of usage of clozapine in Christchurch, New Zealand, including daily dose, indication and use of drug concentration monitoring. METHOD: Patients (n=353) were identified retrospectively from the pharmacy computer system. Data gathered included patient demographics, the daily clozapine dose and the number of occasions that clozapine drug concentration monitoring occurred. In addition, each psychiatrist who had prescribed clozapine was surveyed, regarding their indications for the use of clozapine and their use of clozapine drug concentration monitoring. RESULTS: The majority (63%) of patients on clozapine were male. The mean age of the patients was 43 years (range 15-88 years). The mean daily dose of clozapine was 325 mg (range 12.5-900 mg). Patients over the age of 65 years were on a significantly lower dose (mean=143 mg, 95% CI=103-183 mg) compared with those under 65 years of age (mean=350 mg, 95% CI=330-370 mg). The median duration of treatment on clozapine was 4 years. Fifty-one percent of patients had undergone drug concentration monitoring, the majority on multiple occasions. In females, increasing age correlated with an increase in dose-corrected plasma clozapine concentrations (r(2)=0.29, p<0.001). This was not demonstrated in the male population. Of the psychiatrists surveyed, 44% prescribed clozapine for unlicensed indications and 79% used clozapine drug concentration monitoring in their patients. This was most commonly performed to assess compliance or confirm toxicity. CONCLUSIONS: The mean daily dose of clozapine of 325 mg was similar to that found in other studies. An age-related decline in dose was observed, probably due to different indications, with many of the elderly patients receiving clozapine for Parkinsonian related symptoms. There was also an age-related decline apparent in clearance in females. Clozapine was often used for unlicensed indications, and a clear majority of psychiatrists use drug concentration monitoring. |
| | |
Authors:
|
Andrew McKean; Jane Vella-Brincat; Evan Begg |
Related Documents
:
|
108715 - Variability of prolactin response to intravenous and intramuscular haloperidol in norma... 2878445 - Spontaneous chewing movements in rats during acute and chronic antipsychotic drug admin... 16598965 - Pharmacokinetic profile of long-acting injectable risperidone at steady-state: comparis... 15316715 - Discriminative stimulus properties of the atypical antipsychotic clozapine and the typi... 16647535 - Evaluation of super-high-dose steroid therapy for sudden sensorineural hearing loss. 3564085 - Identification and quantification of 6 beta-hydroxydexamethasone as a major urinary met... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists Volume: 16 ISSN: 1440-1665 ISO Abbreviation: Australas Psychiatry Publication Date: 2008 Aug |
Date Detail:
|
Created Date: 2008-07-31 Completed Date: 2008-11-04 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 9613603 Medline TA: Australas Psychiatry Country: England |
Other Details:
|
Languages: eng Pagination: 263-7 Citation Subset: IM |
Affiliation:
|
Pharmacy Department, Hillmorton Hospital, Christchurch, New Zealand. andrew.mckean@cdhb.govt.nz |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Age Factors Aged Aged, 80 and over Antipsychotic Agents / adverse effects, pharmacokinetics, therapeutic use* Clozapine / adverse effects, pharmacokinetics, therapeutic use* Dose-Response Relationship, Drug Drug Approval Drug Monitoring / utilization Drug Prescriptions / statistics & numerical data* Drug Utilization / statistics & numerical data Female Humans Male Metabolic Clearance Rate / physiology Middle Aged Retrospective Studies Schizophrenia / blood, drug therapy* Utilization Review |
| Chemical | |
Reg. No./Substance:
|
0/Antipsychotic Agents; 5786-21-0/Clozapine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of Cultivation Conditions on the Production of gamma-PGA with Bacillus subtilis ZJU-7.
Next Document: In situ infrared spectroscopic investigation of Perna canaliculus mussel larvae primary settlement.